Cell Signaling & Oncology

Axon Ligands™ for Cell Signaling & Oncology Research

The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer. During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. These interconnected pathways are being deciphered, but understanding the alterations that lead to cancer and correcting them is a substantial challenge. Among the key pathways are those controlling cell proliferation, which coordinate a response to the cellular environment, with the mTOR kinase as a critical node. Tumour development is influenced by infections and inflammation, and the complex role of the nuclear factor-B transcription factors is being unravelled. Expansion of tumour cells depends on nutrient supply and vascularization, which is orchestrated by the transcription factor known as HIF. And the metastatic spread of primary tumours to other organs is facilitated by many signaling pathways[1],[2].

Cell Signaling and Oncology products Library

For your convenience, you can order a library of all of our Cell Signaling and Oncology research related products. Make your personal library by cherry picking products of your interest from our comprehensive list (>800 products), or order all together not to miss any. The libraries will be shipped as 10 mM solutions (in DMSO, 250 µL of each selected Axon Ligand™) on a 96-well microtiter plate with a clear map of its contents.

Simply download our comprehensive list of epigenetics products below (Microsoft Excel (.xls)), check the products to be included, and return your list to order the library of your preference.

Axon Ligands™ for Epigenetic research   Axon 5051 - Cell signaling and Oncology Library.xls                   


[1] A. Eccleston, R. Dhand. Signalling in cancer. Nature 441, 423, editorial note
[2] G.S. Martin. Cell signaling and cancer. Cancer Cell. 2003 Sep;4(3):167-74.

Items 1 to 30 of 50 total

per page
  1. 1
  2. 2
Axon ID Name Description From price
1291 AEG 3482 JNK inhibitor €90.00
4217 AS-703026 Potent, selective and orally bioavailable small molecular inhibitor of MEK1/2  Recently added Inquire
2179 ASK1 Inhibitor 10 Potent, selective, and orally bioavailable ASK1 inhibitor €130.00
1516 AZD6244 MEK1 and MEK2 inhibitor €60.00
1999 AZD8330 MEK 1 inhibitor €105.00
2002 Bentamapimod JNK inhibitor, which inhibited JNK1, JNK2 and JNK3 €70.00
1358 BIRB 796 MAPK inhibitor (p38 specific) €65.00
1809 BIX 02189 MEK5 inhibitor; ERK5 inhibitor €110.00
3346 BIX02188 Potent MEK5 inhibitor €110.00
1808 BIX02188-Me MEK5 inhibitor; ERK5 inhibitor €110.00
2856 BMS 582949 Inhibitor of p38α MAPK €155.00
2025 CC-401 ATP-competitive JNK inhibitor €120.00
2634 CC-930 Potent, selective, and orally active anti-fibrotic JNK inhibitor €95.00
1694 FR 180204 ERK inhibitor; AP-1 inhibitor €95.00
3741 GDC-0994 ERK1/2 inhibitor Inquire
1761 GSK 1120212 MEK1 and MEK2 inhibitor €70.00
3059 GW 284543 hydrochloride Selective MEK5 inhibitor €95.00
2361 JNK-IN-8 Remarkably potent and selective covalent inhibitor of JNK €95.00
1895 LY 2228820 Inhibitor of p38 MAPK €105.00
3893 LY-3214996 Orally bioavailable, potent and highly selective inhibitor of ERK1 and ERK2 Inquire
2366 NG 25 trihydrochloride Type II inhibitor of TAK1 (MAP3K7) and MAP4K2 (GCK) €75.00
1814 NQDI 1 Inhibitor of apoptosis signal-regulating kinase 1 (ASK1) €115.00
1408 PD0325901 MEK1 and MEK2 inhibitor €50.00
1365 PD169316 MAPK inhibitor (p38 specific) €95.00
1368 PD184352 MEK 1 inhibitor €80.00
1223 PD98059 MEK inhibitor €80.00
2107 PF 431396 Dual FAK(PTK2) and PYK2 inhibitor €80.00
4215 PF-562271 Potent, selective, ATP-competitive and reversible dual FAK/PYK2 inhibitor  Recently added €110.00
1837 PH 797804 Inhibitor of p38α MAPK €115.00
1364 SB 202190 MAPK inhibitor (p38 specific) €95.00

Items 1 to 30 of 50 total

per page
  1. 1
  2. 2
Please wait...